Jane Street’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,124
| Closed | -$164K | – | 6779 |
|
|
2024
Q1 | $164K | Buy |
+11,124
| New | +$164K | ﹤0.01% | 5102 |
|
|
2023
Q2 | – | Sell |
-37,307
| Closed | -$459K | – | 6349 |
|
|
2023
Q1 | $459K | Buy |
+37,307
| New | +$459K | ﹤0.01% | 3757 |
|
|
2018
Q1 | – | Sell |
-13,279
| Closed | -$107K | – | 3943 |
|
|
2017
Q4 | $107K | Buy |
+13,279
| New | +$107K | ﹤0.01% | 2875 |
|
|
2016
Q3 | – | Sell |
-2,257
| Closed | -$96K | – | 3250 |
|
|
2016
Q2 | $96K | Sell |
2,257
-3,440
| -60% | -$146K | ﹤0.01% | 2467 |
|
|
2016
Q1 | $375K | Buy |
5,697
+4,328
| +316% | +$285K | ﹤0.01% | 1791 |
|
|
2015
Q4 | $85K | Sell |
1,369
-7,857
| -85% | -$488K | ﹤0.01% | 2491 |
|
|
2015
Q3 | $618K | Buy |
9,226
+6,202
| +205% | +$415K | ﹤0.01% | 1432 |
|
|
2015
Q2 | $294K | Buy |
3,024
+804
| +36% | +$78.2K | ﹤0.01% | 1918 |
|
|
2015
Q1 | $207K | Buy |
+2,220
| New | +$207K | ﹤0.01% | 1976 |
|
|
2014
Q4 | – | Sell |
-40,947
| Closed | -$2.83M | – | 2686 |
|
|
2014
Q3 | $2.83M | Buy |
+40,947
| New | +$2.83M | 0.03% | 295 |
|
|
2014
Q2 | – | Sell |
-4,498
| Closed | -$178K | – | 3100 |
|
|
2014
Q1 | $178K | Buy |
4,498
+2,462
| +121% | +$97.4K | ﹤0.01% | 2121 |
|
|
2013
Q4 | $85K | Buy |
+2,036
| New | +$85K | ﹤0.01% | 1936 |
|
|
2013
Q3 | – | Sell |
-4,886
| Closed | -$259K | – | 3038 |
|
|
2013
Q2 | $259K | Buy |
+4,886
| New | +$259K | ﹤0.01% | 1737 |
|